← Eichor
Study identifier: NCT05487664 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

RM1 Project 2 - tAN fMRI

Condition: Auricular Stimulation  ·  Sponsor: Medical University of South Carolina

PhaseNA
Planned participants96
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

In this one-visit, randomized, double-blind, sham-controlled trial, we plan to use a novel concurrent transcutaneous auricular neurostimulation (tAN) paradigm during functional magnetic resonance imaging (fMRI) paradigm in 96 individuals to determine whether tAN administered to two cranial nerves simultaneously produces greater neurophysiologic effects than stimulating solely to the auricular branch of the vagus nerve (ABVN) or the auriculotemporal nerve (ATN; branch of trigeminal nerve) alone. Within the MRI scanner, each participant will be connected to a series of electrodes that stimulate 4 targets (ABVN only, ATN only, ABVN plus ATN, and Sham).

This description comes directly from the study's public registry record.

Talk to the study team

Bashar Badran, PhD  ·  843-792-6076  ·  badran@musc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University of South Carolina Institute of PsychiatryCharleston, South Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05487664